Uzbekistan plans Biome center for cell technologies and genomics
Uzbekistan is moving ahead with a Biome center dedicated to cell technologies, genomics, and biobanking, aiming to strengthen its position in advanced bioscience research.
Natural killer cell 2 articles
Natural killer cells are innate lymphocytes that can kill stressed, infected or transformed cells without requiring the antigen-specific receptor rearrangement used by T and B cells. Their activity reflects a balance of activating and inhibitory receptors, including missing-self recognition, NKG2D signaling and CD16-mediated antibody-dependent cytotoxicity. The tag refers to the immune-cell type and its biology, not to a specific NK-cell therapy product or to cytotoxic lymphocytes as a broader category.
Arovella Therapeutics gets FDA clearance to start first human trial of ALA-101 cell therapy
Arovella Therapeutics has received FDA clearance to begin Phase 1 clinical testing of its allogeneic cell therapy ALA-101 targeting CD19-positive blood cancers.